NRNP 6665 Week 3 Assignment 1; Prescribing for Children and Adolescents (ADHD)

Course : NRNP 6665 PMHNP Care Across the Lifespan I
Submitted : Year 2022
Contributed : Labeach
  • $15.00
  • NRNP 6665 Week 3 Assignment 1; Prescribing for Children and Adolescents (ADHD)

Week 3: Prescribing for Children and Adolescents (ADHD) Student Name College of Nursing-PMHNP, Walden University NRNP 6665: Psychiatric-Mental Health Nurse Practitioner Care Across the Lifespan I Elvis Ngyia Date Introduction Attention-Deficit/Hyperactive Disorder (ADHD) is one of the most diagnosed psychiatric disorders in children. According to the Centers for Disease Control and Prevention [CDC] (2016), there are approximately 6.1 million children who have already been diagnosed with ADHD in the United States. This represents 9.4% of all the children in the country. The disorder causes abnormal hyperactivity and impulsiveness in children, which impedes their ability to sit down, focus and learn in school. These children, therefore, end up not performing to the best of their ability. Fortunately, some treatments have proven to reduce the symptoms and improve the children’s focus and attention. Treatment of ADHD Some of the most common treatments of ADHD include the use of FDA-approved medication, off-label medications, and non-pharmacological interventions such as therapy, nutrition, and exercise. According to Ghanizadeh (2018), the first-line medication treatment for ADHD is stimulants. There are many types of stimulants approved for the treatment, and all have similar efficacy. The only difference is the dosing, duration of action, and sid

 

Related Products

NRNP 6665 Week 6 Midterm_Drugs

$15.00

NRNP 6665 Final Exam (Collection)

$125.00

Update cookies preferences